The group's principal activity is to develop and market pharmaceutical products that focus on urology and sexual health. In addition to the development of follow-on products for androgen replacement, the group is pursuing product opportunities for other disorders. Major brands of the group are testim and auxilium logo. The group entirely operates in United States.
Executive Information
Name
Title
Email
James Fickenscher
CFO
N/A
Jennifer Stacey
Exec. VP, General Counsel - Human Resources, Sec.
N/A
Jyrki Mattila
Exec. VP - Business Development, Research & Development, and Technical Operations
